Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

We herein report a case of congestive heart failure which developed during osimertinib treatment. A 78-year-old woman presented with mild exertional dyspnea three weeks after starting osimertinib for the treatment of epidermal growth factor receptor (EGFR) T790M-positive non-small cell lung cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Hiromi, Ichihara, Eiki, Kano, Hirohisa, Ninomiya, Kiichiro, Tanimoto, Mitsune, Kiura, Katsuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596283/
https://www.ncbi.nlm.nih.gov/pubmed/28781309
http://dx.doi.org/10.2169/internalmedicine.8344-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596283/
https://www.ncbi.nlm.nih.gov/pubmed/28781309
http://dx.doi.org/10.2169/internalmedicine.8344-16

Ejemplares similares